284 related articles for article (PubMed ID: 7594328)
1. Eradication of Helicobacter pylori with lansoprazole and clarithromycin in gastric ulcer patients.
Shimoyama T; Munakata A; Mizuki I; Akagi T; Fukuda S; Ohkawa K; Yoshida Y; Aisawa T; Sakata Y; Fukushi M
J Clin Gastroenterol; 1995; 20 Suppl 2():S125-7. PubMed ID: 7594328
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of lansoprazole in eradication of Helicobacter pylori.
Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
[TBL] [Abstract][Full Text] [Related]
3. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
[TBL] [Abstract][Full Text] [Related]
4. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Shimoyama T
J Clin Gastroenterol; 1995; 20 Suppl 2():S132-5. PubMed ID: 7594330
[TBL] [Abstract][Full Text] [Related]
5. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Ahuja V; Dhar A; Bal C; Sharma MP
Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Katoh M; Asaka M; Kudoh M; Kagaya H; Katagiri M; Takeda H
J Clin Gastroenterol; 1995; 20 Suppl 2():S112-4. PubMed ID: 7594324
[TBL] [Abstract][Full Text] [Related]
8. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
[TBL] [Abstract][Full Text] [Related]
10. Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Isomoto H; Inoue K; Furusu H; Nishiyama H; Shikuwa S; Omagari K; Mizuta Y; Murase K; Murata I; Kohno S
Helicobacter; 2003 Apr; 8(2):111-9. PubMed ID: 12662378
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
13. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Sieg A; Sellinger M; Schlauch D; Hörner M; Fuchs W
Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Niv Y
Dig Dis Sci; 2005 May; 50(5):839-41. PubMed ID: 15906754
[TBL] [Abstract][Full Text] [Related]
15. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
16. Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Uygun A; Kadayifçi A; Yeşilova Z; Savaş MC; Ateş Y; Karslioğlu Y; Ciğerim M; Bağci S; Dağalp K
Turk J Gastroenterol; 2004 Dec; 15(4):219-24. PubMed ID: 16249974
[TBL] [Abstract][Full Text] [Related]
17. Dual therapy with lansoprazole and clarithromycin for eradication of Helicobacter pylori.
Takimoto T; Kimura K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Ido K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S63-6. PubMed ID: 8574739
[TBL] [Abstract][Full Text] [Related]
18. Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
Maconi G; Russo A; Imbesi V; Cucino C; Bianchi Porro G
Dig Liver Dis; 2000 May; 32(4):275-80. PubMed ID: 11515622
[TBL] [Abstract][Full Text] [Related]
19. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.
Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
